Disruptive Pharma

About Disruptive Pharma

Disruptive Pharma is a pharmaceutical technology company developing and commercializing Formulite®, a patented formulation platform for poorly soluble drugs. Based on mesoporous magnesium carbonate (MMC), Formulite® enables stable amorphous formulations with high drug loading, improved solubility and bioavailability, and efficient manufacturing.

  • Country/Region:
    Sweden
  • Founded:
    2021
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Pharmaceutical company
Primary activities
Contract Research Organisation
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
  • Karolinska Institute Science Park, Box 5216, 10245, Stockholm / Uppsala, Stockholm, Sweden